Cliniverse Canada Inc.

What Cliniverse Canada Inc. does

Cliniverse Canada Inc., operating in the United States as Cliniverse Research, LLC, is a privately held Site Management Organization (SMO) that connects pharmaceutical sponsors and contract research organizations (CROs) with a network of 300-350+ independently owned clinical research sites across the United States. The company is headquartered in Champaign, Illinois, with a secondary office in Oak Park, Illinois, and operates with a small core team of 11-50 employees that coordinates regulatory, contracting, and study-startup activities on behalf of network sites.

The platform spans more than 10 therapeutic areas, including Neurology, Oncology, Cardiology, Women's Health, Psychiatry, Respiratory, Endocrine/Metabolic, Inflammation/Pain, Gastroenterology, and Dermatology. Cliniverse aggregates site capabilities, negotiates Clinical Trial Agreements (CTAs), and claims a 4-6 week study startup timeframe versus typical industry norms, positioning itself as a faster, lower-friction channel for sponsor site activation and for independent sites seeking trial opportunities.

Cliniverse operates a two-sided, performance-based business model. Site network membership is free (freemium), lowering the barrier for independent practices to join; Cliniverse only earns a contingency/transaction fee when trials at its sites are successfully reimbursed. Named CRO and sponsor relationships visible on the company's marketing materials include Bausch Health, ClinChoice, Novidea, CBCC Global Research, Allakos, Alto, and ICON, indicating a diversified demand-side book. No external funding rounds, acquisitions, or AI/ML capabilities are disclosed in the available data.

Name

Cliniverse Canada Inc.

Legal name

Cliniverse Research, LLC

Website

https://cliniverseresearch.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Cliniverse Canada Inc. (operating as Cliniverse Research, LLC) is a U.S.-based Site Management Organization running a free-to-join network of 300-350+ independent clinical trial sites, connecting sponsors and CROs with sites across 10+ therapeutic areas on a contingency-fee basis.

Ownership category

akta.pro rank

Product category

Clinical Research Site Management Services

NAICS

Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (541)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAAAI

Patient Recruitment, Site Feasibility & Trial Enablement CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

Keywords

• Clinical site management
• Site management organization
• Clinical trial services
• Clinical research network
• Trial site coordination

Headquarters

HQ city

Oak Park

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Contingency/Performance-Based Compensation: Cliniverse operates on a risk-share model where they are only compensated if the research site gets reimbursed by the sponsor. Compensation is based on the value received from the sponsor's budget, which varies from project to project. This 'no win, no fee' approach means payment is contingent on successful trial execution and reimbursement.
2. Site Network Services: Services to affiliated research sites are provided at no initial cost. The company supplies clinical trial opportunities, promotes sites to sponsors, and provides support services. Revenue is generated only when a site is selected to participate in a clinical trial through Cliniverse Research.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Cliniverse Research operates as a Site Management Organization (SMO) that connects pharmaceutical sponsors, medical device companies, and Contract Research Organizations (CROs) with a curated network of 300+ independently owned, pre-qualified clinical research sites across the United States. The company delivers study startup coordination, centralized budget and contract negotiation, regulatory document management, and dedicated study manager liaison services for Phase I through Phase IV trials, operating on a contingency-based compensation model.

Product overview

Cliniverse Research is a Site Management Organization (SMO) operating as a centralized platform connecting Principal Investigators and clinical research sites with sponsors and Contract Research Organizations (CROs). The core offering consists of a network of 300+ independently owned clinical sites across the United States, supported by study manager liaison services, budget negotiation services, and regulatory document management. The platform enables sponsors to access pre-screened sites matching their geographic and therapeutic requirements, while offering investigators access to clinical trial opportunities at no upfront cost. Services span Phase I through Phase IV clinical trials, with dedicated support for site selection, contract negotiation, and study startup coordination.

Differentiator

Problem solved

Functional benefit

Products and services

• Site Management Organization (SMO) Services

Quantifiable outcome

• 4-6 weeks study startup timeline after initial contact
• +2 more outcomes

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• Various Pharmaceutical Companies (Unnamed)coreStrategic or Co-development PartnerPharmaceutical companies partnering with Cliniverse for clinical trial site selection and study execution. Partners include companies whose logos appear on the website, representing drug development sponsors seeking clinical research sites.
• Various Contract Research Organizations (CROs)coreStrategic or Co-development PartnerCRO partners including ClinChoice, Novidea, CBCC Global Research, and others who work with Cliniverse for site network access and clinical trial coordination services.
• Bausch HealthminorStrategic or Co-development PartnerPharmaceutical company sponsor for clinical trials, logo displayed as partner/sponsor of Cliniverse Research network.
• ClinChoiceminorStrategic or Co-development PartnerCRO partner, logo displayed as collaborator on Cliniverse Research website.
• CBCC Global ResearchminorStrategic or Co-development PartnerGlobal CRO services partner, logo displayed as collaborator on Cliniverse Research website.
• AllakosminorStrategic or Co-development PartnerBiotechnology company conducting clinical trials, logo displayed as sponsor partner.
• AltominorStrategic or Co-development PartnerCRO partner for clinical operations, logo displayed as collaborator on Cliniverse Research website.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Syneos Health: Syneos Health combines CRO services with site solutions (formerly Syncope) and a clinical site network. It offers sponsors an integrated biopharma solution that competes with Cliniverse's site network for Phase I-IV studies.
• ICON plc: ICON (including legacy PRA Health) is a top-tier global CRO with site-network capabilities across all phases. Listed as a Cliniverse CRO partner on the website, ICON is a direct large-scale incumbent competing for sponsor site-selection and management engagements.
• IQVIA: IQVIA is the largest global CRO with an integrated site management organization, central lab, and proprietary R&D technology stack. It competes with Cliniverse for sponsor site-selection work but operates at vastly greater scale and offers bundled CRO/site/lab services.
• Medpace: Medpace is a mid-to-large CRO with strong site relationships and full-service clinical operations. It competes for sponsor trial work across the same therapeutic areas Cliniverse covers and has more established sponsor contracts.

Direct peers

• ClinChoice: ClinChoice is a global CRO that partners with Cliniverse for site network access. As a CRO of comparable mid-market size, it overlaps with Cliniverse's therapeutic breadth and sponsor segment, and is listed as an active partner on Cliniverse's site.
• Clinipace Worldwide: Clinipace is a mid-sized, technology-enabled CRO and SMO focused on small-to-mid biopharma sponsors. It is comparable to Cliniverse in scale and in its mix of CRO plus site-management services for Phase I-IV programs.
• WCG Clinical: WCG is a clinical trial services company specializing in IRB review, site management, and study-startup acceleration. It is the most direct US-focused competitor to Cliniverse's SMO + regulatory/startup coordination offering.
• CBCC Global Research: CBCC Global Research is a CRO offering clinical operations across multiple regions and is listed as a Cliniverse CRO partner. It is comparable in size and service mix, and competes for similar Phase I-IV engagements from mid-market biopharma sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cliniverseresearchllc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cliniverse Canada Inc.